Analyzing recent rapamycin clinical trials for anti-aging, focusing on optimal dosing, safety, and the shift from off-label use to evidence-based protocols in longevity research. New human trials on r...
ARPA-H’s PROSPR program directs over $50 million to aging trials, advancing drugs like Cambrian’s rapamycin analog and Linnaeus’s GPER-targeter, signaling a shift in treating aging a...
Recent studies show mTOR inhibitors like rapamycin reduce DNA damage and senescence in immune cells, offering a new approach to enhance healthy aging and combat age-related immune decline. New researc...
Explore the science of autophagy, its role in cellular health, and its connection to longevity and disease prevention. Learn how fasting, exercise, and nutrients like spermidine can enhance this proce...
